Astrazeneca Pharma India Q1 Results

  • BSE: 506820
  • NSE: ASTRAZEN
  • ISIN: INE203A01020
  • Sector: Major Drugs
BSE
6,455.4118.50 (1.87%)
Volume1.48 K
Updated: Mon 25 Nov, 2024 | 15:58:52
NSE
6,457.15137.30 (2.17%)
Volume14.74 K
Updated: Mon 25 Nov, 2024 | 15:44:21
Today: 6,313.55
6,486.75
52-Wk: 4,050.15
8,139.85

Q1 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Astrazeneca Pharma India Q1 Results

    *All figures in crores except per share values
    Fiscal PeriodJun 24Mar 23QoQ CompJun 23YoY Comp
    Total Revenue 387.52284.70-%295.47-%
    Selling/ General/ Admin Expenses Total 78.3181.06-%76.02-%
    Depreciation/ Amortization 3.914.25-%3.80-%
    Other Operating Expenses Total 40.7045.17-%41.62-%
    Total Operating Expense 410.92269.34-%232.02-%
    Operating Income -23.4015.36-%63.45-%
    Net Income Before Taxes -15.1623.28-%71.40-%
    Net Income -11.7917.27-%53.86-%
    Diluted Normalized EPS 10.2618.84-%21.54-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts